Q2 FY26 results: revenue up 16 percent, PAT up 22 percent; Rs 8 interim dividend
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.4 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY26 consolidated revenue rose 16.2 percent YoY to Rs. 13,637.11 lakhs; net profit up 22 percent to Rs. 5,720.99 lakhs. H1 FY26 revenue Rs. 23,027.61 lakhs, net profit Rs. 8,370.73 lakhs. Board declared Rs. 8 per share interim dividend with record date Nov 19. Approved sale of up to 9.9 percent stake each in CareEdge Global IFSC to SBI and NSEIX for Rs. 2.97 crore each. Dr. Bimal Patel appointed as Independent Director for three years.
Solid earnings growth and dividend payout reflect healthy operations; minority stake sale in CGIL brings SBI and NSEIX as partners.